About the Self-Check

This Self-Check is designed to be used as a self-evaluation tool. This is not the tool to use for submission to receive certification, but will help you prepare for that process.  
 
When using the Self-Check, feedback is provided through a report at the conclusion; however, the AOC Department for Therapeutic Justice staff are always happy to answer questions, clarify, or provide feedback. 

(Note: If you are currently in your Certification window this is not the survey you are required to complete. Your individual survey will be sent to you via email from the certification team)
 
About this Self-Check: 
  • There are 74 questions and it takes about 30 minutes to complete (NOTE: it will take longer if you are answering the questions as a team and talking about each one)
  • It DOES NOT have to be completed all at once - you can come back to it if you want to complete it in phases.
  • Each question requires an answer.
  • Your progress will be saved as you proceed through the questions.
  • When you have answered every question and click "Done," you will be taken to a screen with a score and responses to each of your answers.
  • Please note that, due to the generic scoring provided by the survey, the completion percentage will NOT be an exact representation of alignment, so the best way to view the feedback is by reading the narrative provided for each question.
  • If you want to save a copy of the responses, use the ctrl+p shortcut and select "save to pdf" in the print dialogue box.
Thank you for incorporating this self-check tool as one way to evaluate your program and measure alignment with the New Mexico Treatment Court Standards.
Page1 / 1
 
 100% of survey complete.

Question Title

* 1. Who is completing this self-check?

Question Title

* 2. With which agencies/organizations does your treatment court have formal agreements (MOUs, Intergovernmental agreements, etc.)? Select all that apply.

Question Title

* 3. Select the areas below that are applicable to your agreement(s) with participating agencies:

Question Title

* 4. Select the team members active in your treatment court. Select all that apply.

Question Title

* 5. With which individual team members do you have signed MOUs in place [Select all that apply]?

Question Title

* 6. MOUs with individual team members include:

Question Title

* 7. Does this treatment court recognize the treatment court calendar as a priority and have a dedicated, separate treatment court docket on a part or full-time basis that is dedicated to the evaluation, diagnosis, treatment and supervision of eligible treatment court participants?

Question Title

* 8. Does this treatment court have written policies and procedures for staff (either court or contract) responsible for supervision / probation / surveillance duties?

Question Title

* 9. Do procedures for the above staff require them to use AOC-approved safety and support applications and complete required minimum training?

Question Title

* 10. Do pre-court staff meetings occur at minimum, at the same frequency as and in advance of, scheduled status hearings?

Question Title

* 11. Which team members regularly communicate in advance of status hearings and via the statewide information management system between status hearings and report on participant progress and/or concerns in treatment or other service areas? Select all that apply.

Question Title

* 12. Please select all that apply:

Question Title

* 13. Does this treatment court use a written consent or release of information form where participants provide voluntary and informed consent about what information will be shared between team members (specifically including progress in treatment and adherence to program requirements).

Question Title

* 14. Treatment court information and records: Select all that apply.

Question Title

* 15. Rules of professional conduct and evidentiary privileges:

Question Title

* 16. Do all participants receive a Participant Handbook upon accepting the terms of participation and entering the treatment court?

Question Title

* 17. What risk and need level participants do you serve. Select all that apply.

Question Title

* 18. Select the risk and need screening and assessment tool(s) used to determine eligibility and service needs. Select all that apply. 

Question Title

* 19. Applicants for this treatment court are denied entry because they are receiving a lawfully prescribed medication for:  Select all that apply.

Question Title

* 20. Participants are not required to discontinue lawfully prescribed medication for psychiatric, substance use, and/or other physical disorders as a condition of graduating from the treatment court.

Question Title

* 21. Do you maintain an appropriate caseload/census based on your capacity to effectively serve all participants in compliance with the NM Treatment Court Standards?

Question Title

* 22. Except as specifically authorized by court order, does your program knowingly employ, or enroll as a participant, any undercover agent or informant?

Question Title

* 23. Is information obtained by an informant or undercover agent, whether or not that agent or informant is placed in a program pursuant to an authorizing court order, used to criminally investigate or prosecute any participant?

Question Title

* 24. Is the primary goal of the program abstinence from alcohol, drugs, and other non-prescribed or non-medically indicated mind-altering substances?

Question Title

* 25. Is any prescribed or medically indicated use of a mind-altering substance predicated upon evaluation and recommendation by a medical professional with expertise in addiction medicine?

Question Title

* 26. Who is the primary team member responsible for case management functions? [Case Management is defined in the NM Treatment Court Standards as "Assessment of participant needs and either providing services or linking the participant to services to meet those needs."] NOTE: This function is required, but may be performed by a program coordinator, treatment staff member, or other team member. It is the function that is required in Standard 4-5: The treatment court team will clearly identify the team member overseeing case management services to ensure coordination of other ancillary services and pro‐social connections, and make referrals as necessary.

Question Title

* 27. Which services below are coordinated through partnership with a primary treatment provider? Select all that apply.

Question Title

* 28. Does this treatment court utilize a single treatment agency to provide the primary treatment services and/or oversee and coordinate the treatment provided from other agencies?

Question Title

* 29. Does this treatment court implement treatment readiness programs for participants who are on waiting lists for comprehensive treatment services (e.g., Curriculum‐Based Motivational Group, Motivational Enhancement Therapy, Motivational Interviewing, etc.)?

Question Title

* 30. How many phases/levels does your treatment court incorporate?

Question Title

* 31. Does the last phases/level of your program emphasize aftercare?

Question Title

* 32. What is the average size of treatment groups?

Question Title

* 33. How many facilitators/leaders are active in each treatment group?

Question Title

* 34. The NM Treatment Court Standards define the clinical case manager as "The individual on the treatment court team responsible for administering a validated assessment instrument to determine whether participants require complementary treatment or social services, providing or referring participants for indicated services, and keeping the treatment court team apprised of participants’ progress. How often do treatment court participants meet with this team member during the first phase?

Question Title

* 35. Which reliable and prosocial individual does the treatment court most frequently enlist to provide firsthand observations to staff about participants’ conduct outside of the treatment court, to help participants arrive on time for appointments, and to help participants satisfy other reporting obligations in the treatment court?

Question Title

* 36. Are participants incarcerated to achieve clinical or social service objectives such as obtaining access to detoxification services or sober living quarters?

Question Title

* 37. Regarding the prescription of psychotropic medicine and/or medication for substance use disorder:

Question Title

* 38. Is any participant denied access to or retention in the program due to their use of FDA-approved medications for the treatment of substance abuse, also known as medication-assisted treatment (MAT), such as methadone; buprenorphine products, including buprenorphine/naloxone combination formulations and buprenorphine mono‐product formulations; naltrexone products, including extended‐release and oral formulations; disulfiram; and acamprosate calcium)?

Question Title

* 39. What is the total active caseload for probation officers or other professionals providing community supervision for the treatment court?

Question Title

* 40. What is the active participant caseload (i.e. total workload) of your clinicians providing case management and treatment?

Question Title

* 41. From the list below, select the documentation the treatment provider maintains for each participant.

Question Title

* 42. From the list below, select the participant documentation the treatment provider shares through written reports or documents in the approved information management system.

Question Title

* 43. Treatment services and participant progress is:

Question Title

* 44. When a participant has tested positive, failed to submit to drug testing, submitted the sample of another, or adulterated a sample the team: Select all that apply.

Question Title

* 45. Are treatment court participants required to comply with the standards, practices, and rules of the treatment court program?

Question Title

* 46. If a participant is terminated from the treatment court because adequate treatment is not available, does the participant  receive an augmented sentence or disposition for failing to complete the treatment court?

Question Title

* 47. When & how are participants informed about the types of incentives and sanctions used in the treatment court and the types of behaviors that result in a range of incentives, sanctions, or therapeutic responses. Select all that apply.

Question Title

* 48. Does the treatment court allow participants to communicate with a defense attorney prior to the imposition of a jail sanction?

Question Title

* 49. When is information regarding incidents of participant noncompliance communicated to all members of the treatment court team to coordinate an appropriate response to the noncompliance incident? Select all that apply.

Question Title

* 50. Responses to participant noncompliance occur:

Question Title

* 51. Does the treatment court team respond to all nonmedically indicated use of intoxicating or addictive substances including alcohol, cannabis (marijuana), and prescription medications, regardless of the licit or illicit status of the substance?

Question Title

* 52. Does the treatment court team rely on medical input to determine whether a prescription for an addictive or intoxicating medication is medically indicated and whether nonaddictive, nonintoxicating, and medically safe alternative treatments are available?

Question Title

* 53. Do responses to noncompliance with drug testing consider potential trauma history, such as when testing triggers memories of sexual abuse?

Question Title

* 54. If a participant is terminated from the treatment court because adequate treatment is not available, is that information provided to the sentencing judge upon remand?

Question Title

* 55. What positive legal outcome is associated with completion of program participation?  Select all that apply.

Question Title

* 56. Does the treatment court reflect a non-adversarial (collaborative) atmosphere?

Question Title

* 57. Do all members of the treatment court team (including the judge) serve as treatment court advocates, representing the treatment court where necessary (for example, in the community, before the federal, state, and local governments, criminal justice agencies, and other public forums, etc.)?

Question Title

* 58. How long has the current primary treatment court judge been serving in that role?

Question Title

* 59. Do the primary and alternate judge rotate responsibilities?

Question Title

* 60. Which team members attend the pre-court staffing [select all that apply]?

Question Title

* 61. Which team members attend the treatment court hearing [select all that apply]?

Question Title

* 62. Information from all staff members and contractors concerning the provision of services and in-program outcomes is:

Question Title

* 63. When was the last outcome evaluation conducted on your program by an independent evaluator?

Question Title

* 64. Does your program provide treatment court information (defined as performance measures) to the local stakeholders, including elected and/or tribal officials, etc., every fiscal year?

Question Title

* 65. When are participant satisfaction surveys used? Select all that apply.

Question Title

* 66. Do you use feedback from participant surveys, review of participant data, and findings from evaluations to make modifications to treatment court operations, procedures and practices?

Question Title

* 67. Regarding program peer review:

Question Title

* 68. How has this treatment court developed and demonstrated material alignment with the NM Treatment Court Standards? Select all that apply.

Question Title

* 69. Select the topics below that reflect the training of treatment court team member(s): Select all that apply. 

Question Title

* 70. Does your treatment court utilize other community‐based services and treatment providers who may be able to augment treatment court services?

Question Title

* 71. Who serves on the treatment court Policy Committee that oversees the operations of the court and establishes a written plan? Select all that apply. 

Question Title

* 72. Who serves on the treatment court Advisory Committee? Select all that apply.

Question Title

* 73. Regarding the Team Response Decision Matrix, which considers the behavior, the participant’s phase, and proximal and distal goals for selecting incentives, therapeutic responses, and sanctions: Select all that apply. 

Question Title

* 74. Regarding alumni services: Select all that apply.

T